Screener
Vir Biotechnology, Inc. VIR Grant revenue — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| License and collaboration revenue | $238,935 | $(495) | $238,894 | $(565) |
| Grant revenue | 11 | 183 | 23 | 1,421 |
| Other revenue | — | 1,526 | — | 3,390 |
| Total revenues | 238,946 | 1,214 | 238,917 | 4,246 |
| Operating expenses: | ||||
| Cost of revenue | — | 11 | — | 11 |
| Research and development | 135,283 | 97,509 | 244,205 | 216,154 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s grant revenue — total revenues?
- Vir Biotechnology, Inc. (VIR) reported grant revenue — total revenues of $11K in Q2 2026.
- How has Vir Biotechnology, Inc.'s grant revenue — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s grant revenue — total revenues decreased by 94.0% year-over-year, from $183K to $11K.
- What is the long-term trend for Vir Biotechnology, Inc.'s grant revenue — total revenues?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s grant revenue — total revenues has grown at a -29.7% compound annual growth rate (CAGR), from $8.35M to $2.04M.
- What does grant revenue — total revenues mean?
- This metric represents the proportion of a company's total revenue derived from government or private research grants rather than commercial product sales or service contracts. It serves as an indicator of the company's reliance on non-dilutive funding to support its research and development pipeline. A higher ratio suggests a business model heavily supported by external research subsidies, which may fluctuate based on grant availability and project milestones.
Ask your AI about Vir Biotechnology, Inc.'s grant revenue — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude